GAIN THERAPEUTICS INC. - COMMON STOCK

Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update

23 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders

22 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Grant Award by Eurostars with Innosuisse for Alpha-1 Antitrypsin Deficiency Research Program

21 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference

09 Mar 2023 07:00:03 By Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data from its Gaucher Disease Program at the 19th Annual WORLDSymposium

27 Feb 2023 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences

02 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference

12 Jan 2023 15:05:00 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update

10 Nov 2022 15:02:00 By Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity in Parkinson’s Disease Patient-Derived Dopaminergic Neurons

26 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer

20 Sep 2022 06:30:00 By Nasdaq GlobeNewswire

Gain Therapeutics Presents New Preclinical Data Demonstrating Potential Disease Modifying Benefits of its Novel Brain Penetrant Small Molecule Candidate GT-02287 in Two Preclinical Models of Parkinson’s Disease

19 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Gain Therapeutics to Present Data at Upcoming Medical Meetings

08 Sep 2022 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics To Participate At The H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 07:00:03 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update

08 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the 2022 BTIG Biotechnology Conference

04 Aug 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the Jefferies Healthcare Conference

02 Jun 2022 07:00:02 By Nasdaq GlobeNewswire

Gain Therapeutics to Participate at the H.C. Wainwright Global Investment Conference

18 May 2022 07:00:01 By Nasdaq GlobeNewswire

Gain Therapeutics, Inc. Reports First Quarter 2022 Financial Results and Business Update

16 May 2022 15:05:01 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Preclinical Data On Its Gaucher Disease Program at IWGGD Symposium

11 May 2022 08:30:00 By Nasdaq GlobeNewswire

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson’s Disease at XXVII IAPRD World Congress

06 May 2022 07:00:00 By Nasdaq GlobeNewswire